We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Diarrhea Drug Abuse Shouldn't End OTC Sales, FDA Hears

Law360, New York (September 11, 2017, 3:20 PM EDT) -- Over-the-counter sales of Johnson & Johnson’s diarrhea drug Imodium A-D shouldn't be halted despite an uptick in fatal overdoses, a top trade group told the U.S. Food and Drug Administration in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.